UNSPSC 51284104: Cefditoren

This classification denotes a cephalosporin antibiotic with the molecular formula C19H18N6O5S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81QS09V3YW, chemically known as cefditoren pivoxil, me-1207, meiact but generally known as cefditoren, which bears US NIH Compound Identifier 444006. European Medicines Agency schedules Cefditoren in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07387MIG.

UNSPSC 51284104 Cefditoren is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The code nominally describes a specific antibiotic pharmaceutical product, yet the two opportunities posted under this code in recent months involve unrelated pharmaceuticals: one a completed piggyback warehouse contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and another a solicitation for Naloxone and drug deactivation systems. The mismatch suggests either inconsistent tagging in the source procurement systems or a data classification error; the code shows little relevant recent activity aligned to cefditoren itself.

The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for $2,999,999.11 over three years under ITB 26482DPHPREPDB53392 (response date September 11, 2026, now closed). Separately, Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to Sanford, Florida; the response deadline was July 26, 2023. Activity appears limited to Illinois and Florida, with no recent solicitations for cefditoren specifically. Firms pursuing this code should verify current procurement intent with state health departments and county public health offices, as the tagging inconsistency limits visibility into genuine demand.